• Program to highlight AM-125 for vertigo and upcoming Phase 3 data readouts for AM-111 and Keyzilen®
  • Featured presentation by Dr. Elias Michaelides, Yale School of Medicine

Zug, Switzerland, May 31, 2017 – Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, today announced that it will host a Key Opinion Leader event on Friday, June 16, 2017, at 8 am EDT in New York City. The event will focus on Auris Medical’s clinical-stage pipeline and feature a presentation by Elias Michaelides, MD, Associate Professor of Surgery, Otolaryngology and Director of the Hearing and Balance Program at the Yale School of Medicine.

To reserve a seat, please contact Cindy McGee via e-mail at investors@aurismedical.com. A live webcast will be available through the Events and Presentations page in the Investors section of the Auris Medical website at www.aurismedical.com and a replay of the presentation will be available following the event.